Insider Trading disclosures for Hepion Pharmaceuticals Inc

The latest disclosure was made by Michael Purcell in Hepion Pharmaceuticals Inc where a trade of 50,000 Restricted Stock Units done was reported to US exchanges on March 6, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Michael Purcell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2024	50,000	50,000	-		-	Restricted Stock Units
S. Gary Jacob	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2024	85,000	102,120	-		-	Stock Options
Patrick Brancaccio John	Director, Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2024	85,000	99,563	-		-	Stock Options
Timothy Block	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2024	85,000	99,562	-		-	Stock Options
Lbiati Kaouthar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Feb 2024	85,000	88,000	-		-	Stock Options
John Cavan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	1,200,000	1,581,060	-		-	Stock Options
Gary S. Jacob	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	250,000	342,785	-		-	Stock Options
John Patrick Brancaccio	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	200,000	291,332	-		-	Stock Options
Thomas H. Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	200,000	291,050	-		-	Stock Options
Robert T. Foster	Director, CEO, CSO and Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	1,900,000	2,501,879	-		-	Stock Options
Petrus Wijngaard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	200,000	260,000	-		-	Stock Options
Timothy Block	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	200,000	291,276	-		-	Stock Options
Arnold Lippa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 May 2021	200,000	291,110	-		-	Stock Options
John Cavan	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 2.00 per share.	18 Feb 2021	10,000	14,800 (0%)	0%	2	20,000	Common Stock
Robert T. Foster	Director, CEO and Director	Purchase of securities on an exchange or from another person at price $ 2.00 per share.	18 Feb 2021	20,000	45,259 (1%)	0%	2	40,000	Common Stock
Petrus Wijngaard	Director	Purchase of securities on an exchange or from another person at price $ 2.20 per share.	16 Feb 2021	10,000	30,000 (0%)	0%	2.2	22,000	Common Stock
Peter Wijngaard	Director	Purchase of securities on an exchange or from another person at price $ 1.91 per share.	18 Dec 2020	20,000	20,000 (0%)	0%	1.9	38,200	Common Stock
Robert T. Foster	Director, CEO and Director	Purchase of securities on an exchange or from another person at price $ 1.58 per share.	08 Dec 2020	25,000	25,259 (0%)	0%	1.6	39,418	Common Stock
John Patrick Brancaccio	Director	Purchase of securities on an exchange or from another person at price $ 1.53 per share.	02 Dec 2020	7,000	7,008 (0%)	0%	1.5	10,710	Common Stock
Gary S. Jacob	Director	Purchase of securities on an exchange or from another person at price $ 1.66 per share.	01 Dec 2020	12,000	12,059 (0%)	0%	1.7	19,920	Common Stock
John Cavan	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 1.62 per share.	25 Nov 2020	4,500	4,800 (0%)	0%	1.6	7,290	Common Stock
Timothy Block	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	30,000	91,276	-		-	Stock Options
Gary S. Jacob	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	30,000	92,785	-		-	Stock Options
John Patrick Brancaccio	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	30,000	91,332	-		-	Stock Options
Thomas H. Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	30,000	91,050	-		-	Stock Options
John Cavan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	160,000	381,060	-		-	Stock Options
Robert T. Foster	Director, CEO,CSO and Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	212,000	601,879	-		-	Stock Options
Arnold Lippa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	30,000	91,110	-		-	Stock Options
Peter Wijngaard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Aug 2020	30,000	60,000	-		-	Stock Options
Peter Wijngaard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2020	30,000	30,000	-		-	Stock Options
Gary S. Jacob	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	60,000	62,729	-		-	Stock Options
John Patrick Brancaccio	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	60,000	61,275	-		-	Stock Options
Thomas H. Adams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	60,000	61,051	-		-	Stock Option
John Cavan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	215,000	221,059	-		-	Stock Options
Robert T. Foster	Director, CEO and CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	380,000	389,879	-		-	Stock Options
Timothy Block	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	60,000	61,220	-		-	Stock Options
Arnold Lippa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Apr 2020	60,000	61,109	-		-	Stock Options
Arnold Lippa	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	970	1,109	-		-	Stock Options
Timothy Block	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	970	1,220	-		-	Stock Options
Robert T. Foster	Director, CEO and CSO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	9,700	9,879	-		-	Stock Options
Gary S. Jacob	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	970	2,729	-		-	Stock Options
John P. Brancaccio	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	970	1,275	-		-	Stock Options
Thomas H. Adams	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	970	1,051	-		-	Stock Options
John Cavan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jul 2019	5,820	6,059	-		-	Stock Options
John P. Brancaccio	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jul 2018	3	3	-		-	Series C Convertible Preferred Stock
Arnold Lippa	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jul 2018	8,625	8,625	-		-	Warrants
Arnold Lippa	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jul 2018	15	15	-		-	Series C Convertible Preferred Stock
John Cavan	CFO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jul 2018	15	15	-		-	Series C Convertible Preferred Stock
John Cavan	CFO	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jul 2018	8,625	8,625	-		-	Warrants
John P. Brancaccio	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	03 Jul 2018	1,725	1,725	-		-	Warrants

Showing 1 to 50 of 93 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low today

Insider Trading disclosures for Hepion Pharmaceuticals Inc

The latest disclosure was made by Michael Purcell in Hepion Pharmaceuticals Inc where a trade of 50,000 Restricted Stock Units done was reported to US exchanges on March 6, 2024.

Screeners based on Insider Trading and SAST parameters